diphenyleneiodonium has been researched along with Disease, Pulmonary in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcos, V | 1 |
| Zhou, Z | 1 |
| Yildirim, AO | 1 |
| Bohla, A | 1 |
| Hector, A | 1 |
| Vitkov, L | 1 |
| Wiedenbauer, EM | 1 |
| Krautgartner, WD | 1 |
| Stoiber, W | 1 |
| Belohradsky, BH | 1 |
| Rieber, N | 1 |
| Kormann, M | 1 |
| Koller, B | 1 |
| Roscher, A | 1 |
| Roos, D | 1 |
| Griese, M | 1 |
| Eickelberg, O | 1 |
| Döring, G | 1 |
| Mall, MA | 1 |
| Hartl, D | 1 |
1 other study available for diphenyleneiodonium and Disease, Pulmonary
| Article | Year |
|---|---|
CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation.
Topics: Animals; Cell Death; Chemokine CXCL2; Cystic Fibrosis; Enzyme Inhibitors; Extracellular Space; Human | 2010 |